Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEXPRESS mexiletine trial in spinal and bulbar muscular atrophy
jRCTs041180106Completed
- Sponsor
- Nagoya University Hospital
- Start
- Aug 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Randomised, double-blind trial of mexiletine in spinal and bulbar muscular atrophy (SBMA) (2 arms), sponsored by Nagoya University Hospital. Started Aug 2017; status: completed.
02
Drugs
mexiletine
03
Conditions
spinal and bulbar muscular atrophy (SBMA)
Beyond the preview
Go deeper on jRCTs041180106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180106.